UNSPSC 51172449: Bismuth/calcium/opium/pectin/zinc

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class GA208. This VA Drug Class (GA208) classifies this compound as belonging to the group ANTIDIARRHEAL AGENTS.

UNSPSC 51172449 Bismuth/calcium/opium/pectin/zinc (Commodity) does not reflect the actual work being solicited by state and local governments under this code. Recent activity shows a sharp mismatch between the code's pharmaceutical-ingredient nominal scope and the substance-testing and pharmacy-benefit services actually being purchased. The Collin County Community Supervision and Corrections Department solicited offender specimen collection and drug testing services—immunoassay screening, LC/MS/MS and GC/MS confirmation, oral fluid and hair testing—under RFP 2026-327 due July 23, 2026, with an estimated contract value of $600,000 and a two-year term commencing September 1, 2026. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration's Office of State Procurement, issued an RFP for generic multi-source pharmaceuticals and over-the-counter products with responses due March 26, 2026, requiring vendors to supply through three authorized wholesalers and certify cGMP and Drug Supply Chain Security Act compliance. The Texas Health and Human Services Commission posted a Request for Information (RFI HHS0017013, April 3, 2026) to gather market intelligence on direct-to-manufacturer pharmacy programs without formal evaluation criteria or award values, exploring vendor capacity for direct contracting outside existing pharmacy benefit manager and group purchasing organization arrangements.

The code shows limited recent activity concentrated in Texas and Minnesota, with county-level criminal justice and state health agencies driving the visible demand. The Collin County opportunity represents corrections-focused substance testing, while MMCAP's pharmaceutical RFP engages a multistate cooperative vehicle spanning state and local facilities across Minnesota and Oregon. The Texas HHS Commission's exploratory RFI suggests emerging state interest in pharmacy benefit innovation but remains pre-solicitation. This code does not appear to track as a reliable procurement signal for pharmaceutical ingredient supply or active pharmaceutical component sourcing; state and local buyers tagging opportunities here are using the code nominally rather than descriptively, making historical performance or forward-looking pipeline estimates under this code unreliable for business development planning.